BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 29268526)

  • 1. Long-term outcomes of stage I NSCLC (≤3 cm) patients following segmentectomy are equivalent to lobectomy under analogous extent of lymph node removal: a PSM based analysis.
    Qu X; Wang K; Zhang T; Shen H; Dong W; Liu Q; Du J
    J Thorac Dis; 2017 Nov; 9(11):4561-4573. PubMed ID: 29268526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Segmentectomy versus lobectomy in early non-small cell lung cancer of 2 cm or less in size: A population-based study.
    Moon MH; Moon YK; Moon SW
    Respirology; 2018 Jul; 23(7):695-703. PubMed ID: 29465766
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival Following Segmentectomy or Lobectomy in Patients With Stage IB Non-small-cell Lung Cancer.
    Hao B; Zhang L; Fan T; Liu B; Jiang W; Hu H; Geng Q
    Front Oncol; 2020; 10():661. PubMed ID: 32500023
    [No Abstract]   [Full Text] [Related]  

  • 4. Selection of the surgical approach for patients with cStage IA lung squamous cell carcinoma: A population-based propensity score matching analysis.
    Shao S; Song G; Wang Y; Yi T; Li S; Chen F; Li Y; Liu X; Han B; Liu Y
    Front Oncol; 2022; 12():946800. PubMed ID: 36081555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical choice for patients with stage I non-small-cell lung cancer ≤2 cm: an analysis from surveillance, epidemiology, and end results database.
    Wu L; Zhao W; Chen T; Yang Y
    J Cardiothorac Surg; 2021 Jul; 16(1):191. PubMed ID: 34233699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lobectomy versus segmentectomy in patients with stage T (> 2 cm and ≤ 3 cm) N0M0 non-small cell lung cancer: a propensity score matching study.
    Wang L; Ge L; You S; Liu Y; Ren Y
    J Cardiothorac Surg; 2022 May; 17(1):110. PubMed ID: 35545793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of Lobectomy and Sublobar Resection for Stage IA Elderly NSCLC Patients (≥70 Years): A Population-Based Propensity Score Matching's Study.
    Zhang B; Liu R; Ren D; Li X; Wang Y; Huo H; Zhu S; Chen J; Song Z; Xu S
    Front Oncol; 2021; 11():610638. PubMed ID: 34026604
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival Rates After Lobectomy, Segmentectomy, and Wedge Resection for Non-Small Cell Lung Cancer.
    Cao J; Yuan P; Wang Y; Xu J; Yuan X; Wang Z; Lv W; Hu J
    Ann Thorac Surg; 2018 May; 105(5):1483-1491. PubMed ID: 29462591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative Effectiveness of Lobectomy, Segmentectomy, and Wedge Resection for Pathological Stage I Non-small Cell Lung Cancer in Elderly Patients: A Population-Based Study.
    Zhang X; Lin G; Li J
    Front Surg; 2021; 8():652770. PubMed ID: 33937317
    [No Abstract]   [Full Text] [Related]  

  • 10. Oncologic outcomes of segmentectomy vs lobectomy in pathologic stage IA (≤2 cm) invasive lung adenocarcinoma: A population-based study.
    Li F; Zhao Y; Yuan L; Wang S; Mao Y
    J Surg Oncol; 2020 Jun; 121(7):1132-1139. PubMed ID: 32108349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Time trend of mediastinal lymph node dissection in stage IA non-small cell lung cancer patient who undergo lobectomy: a retrospective study of surveillance, epidemiology, and end results (SEER) database.
    Pan L; Mo R; Zhu L; Yu W; Lv W; Hu J
    J Cardiothorac Surg; 2020 Aug; 15(1):207. PubMed ID: 32738925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is Lobectomy Actually Worse Than Segmentectomy for All Stage I Non-Small Cell Lung Cancer?
    Ventura L; Fiorelli A; Rossi M; Gnetti L; Natale G; Wang Y; Carbognani P; Fang W; Waller D
    J Surg Res; 2024 Jun; 300():298-308. PubMed ID: 38838427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Choice of Surgical Procedure for Patients With Non-Small-Cell Lung Cancer ≤ 1 cm or > 1 to 2 cm Among Lobectomy, Segmentectomy, and Wedge Resection: A Population-Based Study.
    Dai C; Shen J; Ren Y; Zhong S; Zheng H; He J; Xie D; Fei K; Liang W; Jiang G; Yang P; Petersen RH; Ng CS; Liu CC; Rocco G; Brunelli A; Shen Y; Chen C; He J
    J Clin Oncol; 2016 Sep; 34(26):3175-82. PubMed ID: 27382092
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is wedge resection equivalent to segmentectomy in pathological stage IA (≤2 cm) non-small cell lung cancers?
    Zhang Z; Li F; Chen S; Hu B
    Thorac Cancer; 2024 May; ():. PubMed ID: 38812274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adequate Number of Lymph Nodes Sampled May Determine Appropriate Surgical Modality for Early-Stage NSCLC: A Population-Based Real-World Study.
    Ling L; Zheng H; Lin H; Ge C; Li D; Wu L; Lou Y; Jiang T; Fu J
    Clin Lung Cancer; 2023 May; 24(3):e141-e151. PubMed ID: 36639280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segmentectomy versus lobectomy for small-sized pure solid non-small cell lung cancer.
    Li Z; Xu W; Pan X; Wu W; Chen L
    Thorac Cancer; 2023 Apr; 14(11):1021-1028. PubMed ID: 36882365
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgery for advanced-stage non-small cell lung cancer: lobectomy or sub-lobar resection?
    Hao Z; Liang H; Zhang Y; Wei W; Lan Y; Qiu S; Lin G; Wang R; Liu Y; Chen Y; Huang J; Wang W; Cui F; Goto T; Jeong JY; Veronesi G; Lopez-Pastorini A; Igai H; Liang W; He J; Liu J
    Transl Lung Cancer Res; 2021 Mar; 10(3):1408-1423. PubMed ID: 33889519
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Survival following segmentectomy or lobectomy in elderly patients with early-stage lung cancer.
    Zhang Y; Yuan C; Zhang Y; Sun Y; Chen H
    Oncotarget; 2016 Apr; 7(14):19081-6. PubMed ID: 26934652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Node-Positive Segmentectomy for Non-Small-Cell Lung Cancer: Risk Factors and Outcomes.
    Lutfi W; Schuchert MJ; Dhupar R; Ekeke C; Sarkaria IS; Christie NA; Luketich JD; Okusanya OT
    Clin Lung Cancer; 2019 Jul; 20(4):e463-e469. PubMed ID: 31031205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wedge resection, segmentectomy, and lobectomy: oncologic outcomes based on extent of surgical resection for ≤2 cm stage IA non-small cell lung cancer.
    Al-Thani S; Nasar A; Villena-Vargas J; Harrison S; Lee B; Port JL; Altorki N; Chow OS
    J Thorac Dis; 2024 Mar; 16(3):1875-1884. PubMed ID: 38617767
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.